Page last updated: 2024-11-03

risperidone and Encephalopathy, Hepatic

risperidone has been researched along with Encephalopathy, Hepatic in 1 studies

Risperidone: A selective blocker of DOPAMINE D2 RECEPTORS and SEROTONIN 5-HT2 RECEPTORS that acts as an atypical antipsychotic agent. It has been shown to improve both positive and negative symptoms in the treatment of SCHIZOPHRENIA.
risperidone : A member of the class of pyridopyrimidines that is 2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one carrying an additional 2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl group at position 2.

Research Excerpts

ExcerptRelevanceReference
"Fulminant hepatic encephalopathy has a high mortality."1.33Microdialysis in the management of hepatic encephalopathy. ( Al-Rawi, PG; Czosnyka, M; Gimson, A; Hutchinson, PJ; Menon, DK; O'Connell, MT, 2006)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hutchinson, PJ1
Gimson, A1
Al-Rawi, PG1
O'Connell, MT1
Czosnyka, M1
Menon, DK1

Other Studies

1 other study available for risperidone and Encephalopathy, Hepatic

ArticleYear
Microdialysis in the management of hepatic encephalopathy.
    Neurocritical care, 2006, Volume: 5, Issue:3

    Topics: Acetaminophen; Analgesics, Non-Narcotic; Blood Glucose; Brain; Brain Edema; Critical Care; Dextropro

2006